Skip to main content
Nathan Berger, MD, Hematology, Cleveland, OH, University Hospitals Cleveland Medical Center

NathanABergerMD

Hematology • Cleveland, OH

Professor, Medicine, Case Western Reserve University School of Medicine

Join to view full profile

Dr. Berger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Berger's full profile

Already have an account?

  • Office

    Case Western Reserve University School of Medicine
    10900 Euclid Ave Health Sciences Library
    Cleveland, OH 44106
    Phone+1 216-844-3951
    Fax+1 216-368-3244
  • Is this information wrong?

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1967 - 1968
  • Michael Reese Hospital and Medical Center
    Michael Reese Hospital and Medical CenterInternship, Internal Medicine, 1966 - 1967
  • Drexel University College of Medicine
    Drexel University College of MedicineClass of 1966

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 1983 - 2025

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1980

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Learning About Breakthrough Covid: Vaccines Deter Long Covid but Breakthrough Risks Higher for Cancer, Alzheimer’s Patients
    Learning About Breakthrough Covid: Vaccines Deter Long Covid but Breakthrough Risks Higher for Cancer, Alzheimer’s PatientsJune 8th, 2022
  • Obesity a Major Factor in Rising Rates of Cancer in Young Adults
    Obesity a Major Factor in Rising Rates of Cancer in Young AdultsApril 4th, 2018
  • OZEMPIC-like Drugs May Reduce Risk of One of Deadliest Types of Cancers Rising in Young People, Study Finds
    OZEMPIC-like Drugs May Reduce Risk of One of Deadliest Types of Cancers Rising in Young People, Study FindsDecember 9th, 2023
  • Join now to see all

Grant Support

  • Genetic Determinants Of Barrett'S Esophagus And Esophageal AdenocarcinomaNational Cancer Institute2011
  • Case Center For Transdisciplinary Research On Energetics And CancerNational Cancer Institute2007–2010
  • BioassaysNational Cancer Institute2005–2009
  • Aacr-Trec-Nih Think TANK Conference: Energy Balance And Cancer;Mechanisms And MENational Cancer Institute2008
  • Aging-Cancer Research Program Development At Cwru CCCNational Cancer Institute2003–2007
  • Case Center For Transdisciplinary Research On Energetic*National Cancer Institute2006
  • Transdisciplinary Research On Energetics And CancerNational Cancer Institute2005
  • Faculty RecruitmentNational Cancer Institute2005
  • AdministrationNational Cancer Institute2005
  • General Clinical Research CenterNational Center For Research Resources1996–2002
  • Short Term Training For Minority Students ProgramNational Heart, Lung, And Blood Institute1997–2001
  • Phase II Trials Of TOPO I InhibitorsNational Cancer Institute1994–2000
  • Gcrc-Cap-Dr SpiroNational Center For Research Resources1997
  • Developing And Improving Institutional Animal ResourcesNational Center For Research Resources1997
  • Modulation-Alkylating Agent Chemotherapy-Colon CancerNational Cancer Institute1994–1996
  • Phase II Trials Of Topoisomerase I InhibitorsNational Cancer Institute1995
  • Modulation/Alkylating Agent Chemotherapy--Colon CancerNational Cancer Institute1995
  • Receptor-Targeted Protein Toxins For Brain Tumor TherapyNational Cancer Institute1993–1995
  • Cwru Cancer Research CenterNational Cancer Institute1993–1995
  • Alkylating Agent Chemotherapy And Colon CancerNational Cancer Institute1994
  • Cancer Screening Education For Older Minority AdultsNational Cancer Institute1992–1994
  • Modulation--Alkylating Agent Chemotherapy-Colon CancerNational Cancer Institute1991–1993
  • Cancer Research CenterNational Cancer Institute1992
  • Case Western Reserve University Cancer Research CenterNational Cancer Institute1987–1991
  • Poly(Adpr) Polymerase Inhibitors In Cancer TherapyNational Cancer Institute1986–1987
  • Poly (ADPR) In Genetic Disorders Of DNA RepairNational Institute Of General Medical Sciences1985–1986

Professional Memberships

Hospital Affiliations

Dr. Nathan Berger, Dr. Nathan Berger, MD, Dr. N Berger, Dr. Nathan A Berger